Core Insights - Columbia Sportswear reported revenue of $778.45 million for the quarter ended March 2025, reflecting a year-over-year increase of 1.1% and a surprise of +2.49% over the Zacks Consensus Estimate of $759.57 million [1] - The company's EPS for the same period was $0.75, compared to $0.71 a year ago, resulting in an EPS surprise of +10.29% against the consensus estimate of $0.68 [1] Financial Performance - The stock has returned -19.6% over the past month, contrasting with the Zacks S&P 500 composite's -0.7% change, indicating underperformance relative to the broader market [3] - Columbia Sportswear holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the market in the near term [3] Geographic Sales Breakdown - United States: Net sales of $471.18 million, exceeding the two-analyst average estimate of $465.92 million, but showing a year-over-year decline of -0.7% [4] - Canada: Net sales of $47.58 million, below the average estimate of $49.51 million, with a year-over-year change of -9.2% [4] - EMEA: Net sales of $107.48 million, surpassing the estimated $103.98 million, representing a +2.9% year-over-year increase [4] - LAAP: Net sales of $152.21 million, exceeding the average estimate of $141.39 million, with a year-over-year change of +9.7% [4]

LeMaitre Vascular (LMAT) Q1 2025 Earnings Call May 01, 2025 05:00 PM ET Company Participants Dorian LeBlanc - CFOGeorge LeMaitre - Chairman & CEOShaymus Contorno - Equity Research AssociateDavid Roberts - President & DirectorMichael Petusky - Managing DirectorRick Wise - Managing Director - Medical Technology & SuppliesDaniel Stauder - Director - Equity Research Conference Call Participants Michael Sarcone - AnalystFrank Takkinen - Senior Research AnalystJim Sidoti - AnalystBrett Fishbin - Vice President & ...

Cerus (CERS) Q1 2025 Earnings Call May 01, 2025 04:30 PM ET Company Participants Timothy Lee - Head of Investor RelationsObi Greenman - President and CEOVivek Jayaraman - Chief Operating OfficerKevin Green - VP of Finance & CFOJosh Jennings - Managing DirectorCarol Moore - Senior Vice President of Regulatory Affairs, Quality & ClinicalMatthew Park - Equity Research AssociateVidyun Bais - Equity Research - Vice President Conference Call Participants None - Analyst Operator Good day, ladies and gentlemen. Tha ...

Core Insights - Xerox Holdings Corporation reported $1.46 billion in revenue for Q1 2025, a 3% decline year-over-year, with an EPS of -$0.06 compared to $0.06 a year ago, indicating a significant drop in profitability [1] - The revenue fell short of the Zacks Consensus Estimate of $1.5 billion by 3.19%, and the EPS was also below the consensus estimate of -$0.05, resulting in a surprise of -20% [1] Revenue Breakdown - Services, maintenance, and rentals generated $900 million, below the average estimate of $980.68 million, reflecting a 4% year-over-year decline [4] - Sales revenue reached $557 million, exceeding the average estimate of $490.15 million, marking a 6.5% increase year-over-year [4] - Supplies, paper, and other sales totaled $168 million, significantly lower than the average estimate of $223.04 million, representing a 27.9% decline year-over-year [4] - Equipment sales amounted to $284 million, slightly above the estimated $267.11 million, but showed a 2.1% decrease compared to the previous year [4] - Post-sale revenue was reported at $1.17 billion, below the average estimate of $1.24 billion, indicating a 3.2% year-over-year decline [4] - Mid-range equipment sales reached $198 million, surpassing the average estimate of $175.84 million, with a 2.6% increase year-over-year [4] Stock Performance - Xerox shares have declined by 10.2% over the past month, contrasting with the Zacks S&P 500 composite's decline of only 0.7%, suggesting underperformance in the market [3] - The stock currently holds a Zacks Rank 4 (Sell), indicating potential continued underperformance in the near term [3]

Core Insights - Cullen/Frost Bankers (CFR) reported revenue of $560.42 million for Q1 2025, a year-over-year increase of 7.2% and exceeding the Zacks Consensus Estimate of $550.38 million by 1.82% [1] - The earnings per share (EPS) for the same quarter was $2.30, up from $2.15 a year ago, and also surpassed the consensus EPS estimate of $2.17 by 5.99% [1] Financial Metrics - Net loan charge-offs to average loans were 0.2%, better than the estimated 0.3% [4] - Total earning assets averaged $47.42 billion, slightly below the average estimate of $47.91 billion [4] - Net Interest Margin (FTE) was reported at 3.6%, matching the three-analyst average estimate [4] - Total Non-Performing Loans were $83.53 million, higher than the average estimate of $79.87 million [4] - Book value per common share at the end of the quarter was $61.74, exceeding the estimated $60.28 [4] - Total Non-Interest Income reached $124.01 million, surpassing the average estimate of $117.23 million [4] - Net Interest Income (FTE) was $436.40 million, slightly above the average estimate of $433.15 million [4] - Service charges on deposit accounts totaled $28.62 million, exceeding the estimated $26.79 million [4] - Net Interest Income was reported at $416.22 million, below the average estimate of $417.56 million [4] - Insurance commissions and fees were $21.02 million, higher than the estimated $18.29 million [4] - Trust and investment management fees reached $42.93 million, exceeding the average estimate of $41.20 million [4] - Other charges, commissions, and fees totaled $13.59 million, slightly above the estimated $13.38 million [4] Stock Performance - Shares of Cullen/Frost have returned -6.6% over the past month, compared to the Zacks S&P 500 composite's -0.7% change [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [3]

For the quarter ended March 2025, Medical Properties (MPW) reported revenue of $223.8 million, down 17.5% over the same period last year. EPS came in at $0.14, compared to -$1.23 in the year-ago quarter.The reported revenue represents a surprise of -5.10% over the Zacks Consensus Estimate of $235.83 million. With the consensus EPS estimate being $0.15, the EPS surprise was -6.67%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to dete ...

CVS Health (CVS) reported $94.59 billion in revenue for the quarter ended March 2025, representing a year-over-year increase of 7%. EPS of $2.25 for the same period compares to $1.31 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $92.95 billion, representing a surprise of +1.76%. The company delivered an EPS surprise of +31.58%, with the consensus EPS estimate being $1.71.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street ...

Core Insights - Wesco International reported $5.34 billion in revenue for Q1 2025, a slight year-over-year decline of 0.1% and an EPS of $2.21, down from $2.30 a year ago [1] - The revenue exceeded the Zacks Consensus Estimate of $5.23 billion by 2.10%, while the EPS fell short of the consensus estimate of $2.23 by 0.90% [1] Financial Performance Metrics - Net Sales for Electrical & Electronic Solutions (EES) were $2.07 billion, matching the four-analyst average estimate, with a year-over-year decline of 1.6% [4] - Net Sales for Utility & Broadband Solutions (UBS) were $1.28 billion, below the four-analyst average estimate of $1.36 billion, reflecting a significant year-over-year decline of 19.2% [4] - Net Sales for Communications & Security Solutions (CSS) reached $2 billion, surpassing the $1.82 billion average estimate, with a year-over-year increase of 19.8% [4] Adjusted EBITDA Analysis - Adjusted EBITDA for Corporate was -$128.70 million, slightly worse than the average estimate of -$126.37 million [4] - Adjusted EBITDA for UBS was $138.30 million, below the four-analyst average estimate of $146.25 million [4] - Adjusted EBITDA for CSS was $158.50 million, exceeding the average estimate of $143.46 million, while EES reported $142.60 million, below the average estimate of $163.59 million [4] Stock Performance - Wesco International's shares returned +0.4% over the past month, contrasting with a -0.7% change in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [3]

Altisource Portfolio Solutions (ASPS) Q1 2025 Earnings Call May 01, 2025 08:30 AM ET Company Participants Michelle Esterman - Chief Financial OfficerWilliam Shepro - Chairman and Chief Executive Officer Operator day, and welcome to the Altisource Portfolio Solutions First Quarter twenty twenty five Earnings Call. At this time, all participants are in a listen only mode. After the speaker presentation, there will be a question and answer session. To ask a question during the session, you will need to press 1 ...

公司最新资产负债率为39.26%，在已披露的同业公司中排名第7，较上季度资产负债率增加1.89个百分 点，较去年同期资产负债率减少14.03个百分点。 公司最新毛利率为12.66%，在已披露的同业公司中排名第11，较上季度毛利率减少0.26个百分点，较去 年同期毛利率增加1.35个百分点，实现2年连续上涨。最新ROE为0.62%，在已披露的同业公司中排名第 9，较去年同期ROE减少0.91个百分点。 2025年4月29日，红棉股份(000523.SZ)发布2025年一季报。 公司营业总收入为4.84亿元，在已披露的同业公司中排名第12，较去年同报告期营业总收入减少5461.67 万元，同比较去年同期下降10.14%。归母净利润为1171.37万元，在已披露的同业公司中排名第11，较 去年同报告期归母净利润减少1001.79万元，同比较去年同期下降46.10%。经营活动现金净流入为2.41 亿元，在已披露的同业公司中排名第4，较去年同报告期经营活动现金净流入增加1.64亿元，同比较去 年同期上涨212.95%。 公司最新总资产周转率为0.14次，在已披露的同业公司中排名第5，较去年同期总资产周转率减少0.02 ...